92 related articles for article (PubMed ID: 10220799)
1. An ACTH-producing pituitary carcinoma developing Cushing's disease.
Masuda T; Akasaka Y; Ishikawa Y; Ishii T; Isshiki I; Imafuku T; Ogihara T; Miyazaki H; Asuwa N
Pathol Res Pract; 1999; 195(3):183-7. PubMed ID: 10220799
[TBL] [Abstract][Full Text] [Related]
2. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
[TBL] [Abstract][Full Text] [Related]
3. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M
Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
[TBL] [Abstract][Full Text] [Related]
4. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
5. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease.
Lankford HV; Tucker HS; Blackard WG
N Engl J Med; 1981 Nov; 305(21):1244-8. PubMed ID: 6270557
[TBL] [Abstract][Full Text] [Related]
6. Significant gene expression of insulin-like growth factor II and proliferating cell nuclear antigen in a rapidly growing recurrent pituitary acth-secreting adenoma.
Hashimoto K; Nagano I; Asaba K; Inoue M; Nishioka T; Takao T; Nakajo T; Mori T; Kurisaka M; Otsuka F
Horm Res; 2000; 54(4):198-202. PubMed ID: 11416238
[TBL] [Abstract][Full Text] [Related]
7. [ACTH dependent Cushing's syndrome with an empty sella turcica: report of three cases with emphasis on diagnostic value of selective venous sampling].
Yamamoto N; Negoro M; Yokoe T; Ichihara K; Nakane T; Kuwayama A; Kageyama N
No Shinkei Geka; 1985 Dec; 13(12):1323-8. PubMed ID: 3003618
[TBL] [Abstract][Full Text] [Related]
8. ACTH- and prolactin-producing pituitary gland microadenoma with biphasic features of atypia and intermediate filament expression.
Mittelbronn M; Psaras T; Capper D; Meyermann R; Honegger J
Neuro Endocrinol Lett; 2006; 27(1-2):89-92. PubMed ID: 16648816
[TBL] [Abstract][Full Text] [Related]
9. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
Mahler C; Verhelst J; Klaes R; Trouillas J
Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
[TBL] [Abstract][Full Text] [Related]
10. ACTH secreting pituitary adenoma in an infant of 18 months. Immunohistochemical, electron-microscopic, and in-vitro studies.
Saeger W; Ruttmann E; Lüdecke D
Pathol Res Pract; 1981 Dec; 173(1-2):121-9. PubMed ID: 6278457
[TBL] [Abstract][Full Text] [Related]
11. Neural transformation in a pituitary corticotroph adenoma.
Vidal S; Horvath E; Bonert V; Shahinian K; Kovacs K
Acta Neuropathol; 2002 Oct; 104(4):435-40. PubMed ID: 12200632
[TBL] [Abstract][Full Text] [Related]
12. Adrenocorticotropin-producing pituitary carcinoma with metastasis to the liver in a patient with Cushing's disease.
Suzuki K; Morii K; Nakamura J; Kaneko S; Ukisu J; Hanyu O; Nakagawa O; Aizawa Y
Endocr J; 2002 Apr; 49(2):153-8. PubMed ID: 12081233
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of Cushing's disease.
Fehm HL; Voigt KH
Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
[TBL] [Abstract][Full Text] [Related]
14. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
15. Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence.
Psaras T; Honegger J; Buslei R; Saeger W; Klein D; Capper D; Meyermann R; Mittelbronn M
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):610-5. PubMed ID: 17943697
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
17. [Incidence and clinical manifestation of ACTH-producing pituitary adenoma after bilateral adrenalectomy for Cushing's syndrome (Nelson syndrome)].
Froesch T; Müller J; Labhart A; Froesch ER; Landolt AM
Schweiz Med Wochenschr; 1981 Sep; 111(37):1346-52. PubMed ID: 7291959
[TBL] [Abstract][Full Text] [Related]
18. ACTH-producing pituitary carcinoma presenting as the cauda equina syndrome.
Frost AR; Tenner S; Tenner M; Rollhauser C; Tabbara SO
Arch Pathol Lab Med; 1995 Jan; 119(1):93-6. PubMed ID: 7802565
[TBL] [Abstract][Full Text] [Related]
19. ACTH response to corticotropin releasing hormone in Cushing's disease before and after ketoconazole: in vivo and in vitro studies.
Boscaro M; Sonino N; Rampazzo A; Menegus AM; Mantero F
Horm Metab Res Suppl; 1987; 16():60-2. PubMed ID: 2832292
[TBL] [Abstract][Full Text] [Related]
20. Intracranial dissemination of an ACTH secreting pituitary neoplasm--a case report and review of the literature.
Tonner D; Belding P; Moore SA; Schlechte JA
J Endocrinol Invest; 1992 May; 15(5):387-91. PubMed ID: 1324266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
